Plain-English translation of NCT07157852 on ClinicalTrials.gov โ ยท Source last updated ยท Translation generated ยท How we translate trials
This study doesn't follow the usual testing phases โ it may be an observational study or a different type of research.
This study is testing two medications โ and โ to see which one works better for fibromyalgia, a long-term condition that causes widespread pain, tiredness, and emotional symptoms. Right now, is commonly used to treat fibromyalgia, but it doesn't work well enough for many patients. This medication may offer a better option, but researchers need to compare it fairly with the current standard treatment.
Current treatments for fibromyalgia only help about 25โ40% of patients achieve meaningful pain relief, and many people experience side effects. This trial exists to find out whether the new treatment might help more patients with fewer problems.
You likely qualify ifโฆ
You likely don't qualify ifโฆ
You would be randomly assigned to take either or the new medication as a daily pill over the course of the study. The study involves visits where researchers will check how much your pain has improved, monitor your side effects, and test your liver and kidney function. The exact length and number of visits isn't specified in this description, but you can ask the research team for those details when you contact them.
AI-generated summary from trial data ยท Jun 3, 2026 ยท Not medical advice
China